Kate Amato Foundation Grant Awards

Targeting CTPS1 and nucleotide metabolism in MYC-amplified medulloblastoma

Targeting CTPS1 and nucleotide metabolism in MYC-amplified medulloblastoma

2023

Myron Evans, PhD

Seattle Children’s Research Institute

RNA-nanoparticle (RNA-NP) vaccine for ARMS

RNA-nanoparticle (RNA-NP) vaccine for ARMS

2023

Leighton Elliott, MD

University of Florida Pediatric Cancer Immunotherapy Initiative

Exploiting Aryl Hydrocarbon Receptor (AhR) as a Novel Therapeutic Strategy in MYCN-Amplified Neuroblastoma

Exploiting Aryl Hydrocarbon Receptor (AhR) as a Novel Therapeutic Strategy in MYCN-Amplified Neuroblastoma

2022

Kanita Chaudry

University of Buffalo and Roswell Park Comprehensive Cancer Center

Identification of Genes Regulating NKT cell Anti-tumor Activity using a CRISPR/Cas9 Mutagenesis Screen

Identification of Genes Regulating NKT cell Anti-tumor Activity using a CRISPR/Cas9 Mutagenesis Screen

2022

Gengwen Tian, MD, PhD

Baylor College of Medicine and Texas Children’s Cancer Center

Targeting mutant cohesin protein complex to treat relapsed pediatric Ewing Sarcoma

Targeting mutant cohesin protein complex to treat relapsed pediatric Ewing Sarcoma

2021

Debananda Pati, PhD

Texas Children’s Cancer Center and Baylor College of Medicine

Selective cytotoxic effects of CDK12 inhibition on metastatic osteosarcoma cells

Selective cytotoxic effects of CDK12 inhibition on metastatic osteosarcoma cells

2020

Matthew Harlow, PhD

Dana-Farber Cancer Institute, Harvard Medical School

Elucidating the Role of Invariant Natural Killer T Cells in Neuroblastoma Antitumor Immunity

Elucidating the Role of Invariant Natural Killer T Cells in Neuroblastoma Antitumor Immunity

2019

Hamid Bassiri, MD

University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP)

Transcriptional Addiction in Acute Myeloid Leukemia

Transcriptional Addiction in Acute Myeloid Leukemia

2019

Max Pimkin, MD, PhD

Dana Farber Cancer Institute, Boston Children’s Hospital, Harvard Medical School

The Role of the Macro lncRNA KCNQ1OT1 in Embryonal Rhabdomyosarcoma Tumorigenesis

The Role of the Macro lncRNA KCNQ1OT1 in Embryonal Rhabdomyosarcoma Tumorigenesis

2019

Corrine Linardic, MD, PhD

Duke University School of Medicine

Developing a pediatric B-ALL model to uncover epigenetic mechanisms of relapse from CAR-T cell immunotherapy

Developing a pediatric B-ALL model to uncover epigenetic mechanisms of relapse from CAR-T cell immunotherapy

2018

Dr. Patricia Ernst and Dr. Terry Fry

Human Immunology and Immunotherapy Initiative at University of Colorado School of Medicine and Children’s Hospital of Colorado

The Role of CXCL 10-CXCR3 AXIS in Osteosarcoma Metastasis

The Role of CXCL 10-CXCR3 AXIS in Osteosarcoma Metastasis

2018

Dr. Tsz-Kwong “Chris” Man

Cancer Genomics and Genetics Program at Baylor College of Medicine and Texas Children’s Cancer Center

Novel Targeted Therapy to Eliminate Leukemic Stem Cells in Pediatric Acute Myeloid Leukemia

Novel Targeted Therapy to Eliminate Leukemic Stem Cells in Pediatric Acute Myeloid Leukemia

2018

Dr. Martina Roos, Dr. Vivian Chang and Dr. John Chute

The David Geffen School of Medicine at UCLA